Oncology
Conference Coverage
AI predicts endometrial cancer recurrence
Model uses only digitized histopathology slides, but more validation in other populations is needed.
Conference Coverage
PARP/ATR inhibitor combo shows hints of promise in children with tumors
A phase 1 clinical trial could provide biomarker clues to help guide future studies.
Conference Coverage
Circulating DNA has promise for cancer detection, but faces challenges
Unnecessary procedures and health care challenges could leave Whites as the primary beneficiaries.
News
USPSTF releases updated recommendations on skin cancer screening
“Our recommendations are for patients who present to primary care without symptoms, and after a careful assessment of benefit and harms, we didn’t...
Conference Coverage
Relapsed CLL: New approaches prolong survival
Venetoclax, with a second-generation generation Bruton’s tyrosine kinase inhibitor, can lead patients with relapsed CLL back to remission.
News
Cancer, heart disease vaccines may be ready by 2030, Moderna says
The announcement is yet another sign of what many are calling “the golden age” of vaccine development.
News
Price of CLL Rx rises, despite competition
The cost of ibrutinib keeps going up, in spite of newer treatment options.
News
Survival gains after surgery for small pancreatic NETs?
With many patients potentially missing from the data, “it is very difficult to know that patients with tumors 1.1-2.0 cm in size are really...
Commentary
New colorectal cancer data reveal troubling trends
It has become increasingly apparent that the age profile and associated risks for this cancer are rapidly changing.
News
Healthy lifestyle mitigates effect of childhood cancer
Independent of prior treatment exposures and sociodemographic factors, a healthy lifestyle and absence of hypertension or diabetes were each...